Elypta
PrivateLast Round
Grant
May 1, 2025
Total Funding Raised
$30.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Elypta operates in Healthcare & Life Sciences and is based in Solna. Its latest recorded funding round was a Grant round in May 2025.
Elypta is a biotechnology company that develops a metabolism-based liquid biopsy platform for the early detection and monitoring of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elypta Comparables
Compare Elypta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dxcover | 79% | |
| Biomark Diagnostics Inc. | 77% | |
| CanSense | 73% |
For institutional investors. Book with your work email.
Elypta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Series A | Jun 20, 2022 | ||||
| Seed | Dec 1, 2019 | ||||
| Grant | Feb 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elypta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nina Capital | Seed, Series A |
| Bonnier Capital | Series A |
| Hillclimber | Series A |
| Navigare Ventures | Series A |
| Norrsken Foundation | Seed |
| Industrifonden | Series A, Seed |
| Sciety | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 172% MoM, reaching 3.4K.
- Apr 1, 2026
Monthly visitors grew 96% MoM.
For institutional investors. Book with your work email.
Elypta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elypta's valuation, stock price, and market status.
Is Elypta a public or private company?
Elypta is a private company.
What is the current stock price of Elypta?
Elypta is a private company, so its shares have no public market price. Caplight tracks Elypta's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elypta worth (valuation)?
Valuation information for Elypta is not publicly available.
Can I buy Elypta stock?
Elypta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elypta's last funding round?
Elypta's most recent funding round was Grant on May 1, 2025.
Who are the main investors in Elypta?
Key investors in Elypta include Bonnier Capital, Industrifonden, Sciety, Bonnier Capital.
Will Elypta IPO soon?
No public IPO plans have been announced for Elypta.
How can I track Elypta secondary market activity?
Caplight tracks bids, offers, and trades in Elypta's shares on secondary markets.